Alex Oshmyansky

Alex Oshmyansky is the co-founder and CEO of Mark Cuban Cost Plus Drug Company, a pharmaceutical company that sells generic medications at transparent, cost-plus prices. He is a practicing radiologist who holds an MD from Duke University and a PhD in mathematics from Oxford University. He founded the company in 2018 after becoming frustrated by the high cost of generic drugs, and Mark Cuban provided full financial backing, leading to the company's public launch in 2022.